
The top money raisers in biotech
The Top Line
00:00
Biotech Trends and Investment Strategies
Exploring the rise of dual-track processes in biotech companies, focusing on cutting-edge technologies like AI, RNA editing, and cell therapy for autoimmune diseases. Highlighting the shift towards targeting undrugable diseases and significant financing rounds in areas like neuroscience and cardiovascular breakthroughs.
Transcript
Play full episode